Trending
From Alan Kwong’s dream into a multi-million company, PharmEng Technology has come a long way in 25 years. The company has been offering top-notch services to the Life Science Industry since its establishment in 1997. The specialists here hold expertise in Training, Engineering, Regulatory Affairs, Quality Systems, Validation, and Commissioning & Qualification. The motive is to make sure that its clients can continue to provide the world with high-standard and cost-effective healthcare products.
PharmEng Technology offers a wide array of services to the nutraceutical, medical device, biotechnology, and pharmaceutical sectors. With its help, the company’s clients are competent to meet regulatory requirements from international as well as local bodies and facilitate their production processes. The venture offers them cost-effective and timely solutions to avoid any hurdles and delays they may face.
Initially, the company had limited resources, which is why landing a major project was a challenge. With the relentless efforts over time, the company was able to accomplish successful project execution by producing deliverables on schedule and budget.
Noticing the success, the clients started to award more projects to the company. This is what paved the way for the growth of PharmEng Technology to become a global service provider to the life science industry.
PharmEng Technology aids in the implementation of the latest industry strategies to meet its client’s organizational and regulatory needs. The wide variety of services offered by the company includes regulatory affairs, pharmaceutical consulting, project management, commissioning and qualification, engineering, validation, toxicology, automation engineering solutions, quality systems, thermal mapping, and training.
The PharmEng Technology Team strives to make sure that its clients maintain their competitive advantage as it meets the expectations of a more stringing and evolving regulatory environment. For the same, the company remains updated with the regulatory requirements if WHO, European Union, Asia,United States and Canada. By doing so, it ensures that it will always possess the Global Perspective.
PharmEng Technology works with various clients in the medical device, biotechnology, and pharmaceutical industries. It looks forward to meeting its objective of serving its clients globally through its expertise and specific skillset. Moreover, the company helps its clients form processes that make sure that their services and products are delivered at the highest standards.
For a recent project, PharmEng Technology was hired by an organization that was imposed import alert by FDA with for shipping products to the USA, essentially refusing the products to enter USA. This had a tremendous financial impact on the company because it was not able to sell any products to its major clients in USA.
To help with the remediation, PharmEng Technology was assigned the responsibility to review quality activities, validation, manufacturing functions, as well as laboratory operations. As a result, PharmEng was able to improve the company operations and quality standards resulting in afavorable FDA inspection. Eventually, the import ban was lifted and the company was able to return to normal operations.
The company’s revenue increased from 16 million in 2018 to 53 million in 2022, which is a compounded revenue growth of 35 percent in the period of five years. This clearly explains the extent to which it has been delivering its services successfully. Besides, the target customers of PharmEng Technology are multinational pharmaceutical companies and out of the ten biggest global pharmaceutical companies, five are PharmEng’s clients.
Over the years, PharmEng Technology has gained clients’ trust, which is why it is chosen as the preferred supplier by leading multinational companies. Clients prefer PharmEng for services due to tight project timelines or a lack of expertise in certain area. Alan states, “We strive to ensure that our clients maintain their competitive advantage while meeting the expectations of an evolving and more stringent regulatory environment.”
The company provides monthly internal staff training to ensure that its consultants stay up-to-date with technological advancements and the latest compliance necessities. This aids the clients in producing high-end products efficiently, and more importantly, in compliance with regulatory needs.
With more than 250 staff in Latin America, Asia, Europe, and North America, along with an impressive client base, including Alcon, J&J, Novartis, Sanofi, and Pfizer, PharmEng Technology has established that it is a leading consulting company when it comes to serving multinational pharmaceutical companies in a global facet with a local presence.
Over the years, the company has followed its clients’ path when it came to geographical presence – PharmEng Technology established offices in the USA, Canada, Singapore, Malaysia, Indonesia, Taiwan, Denmark, Ireland, Spain, Puerto Rico, Domenica Republic, and Brazil.
Alan states, “Going forward, PharmEng will continue to expand into the target countries where our multinational clients also have a geographical presence.” Further, in the long run, PharmEng Technology aims to be the top global consulting firm that has a local presence in order to aid clients across the globe effectively and efficiently.
Company Services: PharmEng Technology provides a wide range of consulting services to the pharmaceutical, biotechnology, medical device, and nutraceutical industries.
Company Name: PharmEng Technology
Founding Year: 1997
Office Locations: 410 – 23 Lesmill Rd., Toronto, Ontario Canada M3B 3P6
Official Website of the Company: www.pharmeng.com
Name of the Featured Leader: Alan Kwong
Designation of the Leader: CEO
